These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1977696)

  • 1. Thyroid stimulating hormone receptor antibody in thyroid diseases.
    Vadivelu N; Stephen DC; Kanagasabapathy AS; Seshadri MS
    Indian J Med Res; 1990 Aug; 92():220-3. PubMed ID: 1977696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.
    Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T
    N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of remission after antithyroid drug treatment in Graves' disease.
    Young ET; Steel NR; Taylor JJ; Stephenson AM; Stratton A; Holcombe M; Kendall-Taylor P
    Q J Med; 1988 Feb; 66(250):175-89. PubMed ID: 2902655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease.
    Takasu N; Kamijo K; Sato Y; Yoshimura H; Nagata A; Ochi Y
    Clin Exp Pharmacol Physiol; 2004; 31(5-6):314-9. PubMed ID: 15191404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
    Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies that promote thyroid growth. A distinct population of thyroid-stimulating autoantibodies.
    Valente WA; Vitti P; Rotella CM; Vaughan MM; Aloj SM; Grollman EF; Ambesi-Impiombato FS; Kohn LD
    N Engl J Med; 1983 Oct; 309(17):1028-34. PubMed ID: 6137770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with a radioreceptor assay for TSH-binding inhibiting immunoglobulins (TBII).
    Heberling HJ; Bierwolf B; Lohmann D
    Exp Clin Endocrinol; 1988 Aug; 91(3):355-61. PubMed ID: 2908034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbimazole and the autoimmune response in Graves' disease.
    McGregor AM; Petersen MM; McLachlan SM; Rooke P; Smith BR; Hall R
    N Engl J Med; 1980 Aug; 303(6):302-7. PubMed ID: 6247656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
    Wallaschofski H; Kuwert T; Lohmann T
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thyroid antibodies and their diagnostic value].
    Schneidinger P; Joller-Jemelka H; Grob PJ
    Schweiz Med Wochenschr; 1985 Nov; 115(44):1536-44. PubMed ID: 3841229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Personal experience in the study of thyroid autoimmunity and endocrine exophthalmos].
    Winand R
    Bull Mem Acad R Med Belg; 1989; 144(5-7):363-70; discussion 370-2. PubMed ID: 2575920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased activated T-lymphocytes and normal thyrotropin receptor antibody levels in Graves' disease in long-term remission.
    Peakman M; Hussain M; Cundy T; Vergani D
    J Clin Lab Immunol; 1989 Sep; 30(1):1-5. PubMed ID: 2577115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital thyrotoxicosis in premature infants.
    Smith C; Thomsett M; Choong C; Rodda C; McIntyre HD; Cotterill AM
    Clin Endocrinol (Oxf); 2001 Mar; 54(3):371-6. PubMed ID: 11298090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimum duration of antithyroid drug treatment determined by assay of thyroid stimulating antibody in patients with Graves' disease.
    Edan G; Massart C; Hody B; Poirier JY; Lé Reun M; Hespel JP; Leclech G; Simon M
    BMJ; 1989 Feb; 298(6670):359-61. PubMed ID: 2564286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapse of Graves' disease after medical therapy: predictive value of thyroidal technetium-99m uptake and serum thyroid stimulating hormone receptor antibody levels.
    Wilson R; McKillop JH; Pearson DW; Cuthbert GF; Thomson JA
    J Nucl Med; 1985 Sep; 26(9):1024-8. PubMed ID: 2863338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein-A purified human immunoglobulins: a comparison of thyroid stimulating and thyrotrophin receptor binding activities in thyrotoxicosis.
    Reader SC; Davison B; Beardwell C; Ratcliffe JG; Robertson WR
    Clin Endocrinol (Oxf); 1986 Oct; 25(4):441-51. PubMed ID: 2887306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spin echo nuclear magnetic resonance studies on intact erythrocytes: changes in cellular metabolism as a consequence of carbimazole therapy.
    Reglinski J; Smith WE; Wilson R; Buchanan LM; McKillop JH; Thomson JA
    Clin Endocrinol (Oxf); 1992 Oct; 37(4):319-24. PubMed ID: 1362374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid stimulating and thyrotrophin binding-inhibitory immunoglobulin activity in patients with systemic lupus erythematosus having thyroid function abnormalities.
    Baker JR; Miller FW; Steinberg AD; Burman KD
    Thyroid; 1991; 1(3):229-34. PubMed ID: 1688101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grades of exophthalmos and thyrotropin-binding inhibitory immunoglobulin in patients with myasthenia gravis.
    Okada S; Saito E; Ogawa T; Sadamoto K; Kinoshita M
    Eur Neurol; 1995; 35(2):99-103. PubMed ID: 7796844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-operative thyroid status of patients with Graves' disease is determined by the responsiveness of thyrocyte to TSH under the present thyroid gland remnant.
    Yamashita H; Noguchi S; Murakami N; Watanabe S; Kawamoto H
    Endocr J; 1998 Aug; 45(4):513-7. PubMed ID: 9881901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.